Medigene AG maintained financial guidance for the fiscal year 2023. The Company maintains its guidance on expected revenues to be between EUR 5 and 7 million in 2023 (unchanged).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 EUR | +4.76% | +11.59% | +0.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.98% | 38.9M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Maintains Financial Guidance for the Fiscal Year 2023